NLS Collaboration

At the end of this year Karo Bio will transfer the responsibility of the Rorgamma project to their development parter Pfizer, according to the company’s interim report for the third quarter. The rorgamma project aim to develop treatments for auto immune diseases.

AstraZeneca, together with its global biologics research and development arm, MedImmune, has entered into four new collaborations with the University of Cambridge, building further on their existing partnership. The new agreements build on the existing partnership between AstraZeneca, MedImmune and the University of Cambridge, which includes an oncology research programme and co-location of AstraZeneca scientists […]

The aim is to test secure, cloud-based remote medical device monitoring. Through the collaboration Aerocrine will utilize Microsoft’s cloud services to transmit device telemetry data from physician and company sites in Sweden, UK and US back to Aerocrine for analyses. “The ability to collect vital telemetry data from deployed devices has been a key objective of […]

DanDrit Biotech A/S has signed a contract of collaboration with the University Hospital IRCCS “San Martino”. The collaboration relates to a Phase III adjuvant study of DanDrit’s vaccine in patients with no evidence of disease (“NED”) stage IV colorectal cancer (“CRC”). The primary goal of the study is to evaluate the efficacy of DanDrit’s MelCancerVac (“MCV”) […]

Probi and Pharmavite expand collaboration in the US and international markets. The two companies have signed a new long-term agreement for distribution and marketing of Probi’s probiotic products. Pharmavite launched Probi Digestis capsules based on Probi’s flagship strain LP299V in the US market under the Nature Made brand in 2012 and have accounted for a significant portion of Probi’s […]

AstraZeneca’s global biologics research and development arm MedImmune and Cancer Research UK, with its commercial arm, Cancer Research Technology (CRT), has entered into a collaboration. The aim is to establish a joint laboratory in Cambridge, UK. The new laboratory will focus on the discovery and development of novel biologic cancer treatments over an initial five-year period. AstraZeneca announces that scientists […]